ImmunityBio, Inc. (IBRX) Most Active Options
The 25 most actively traded ImmunityBio, Inc. (IBRX) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.
Data as of Aug 25, 2026, 3:50 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active IBRX Contracts
| Contract | Expiration | DTE | Last | IV | IV rank (30d) | Delta | Open interest | Volume | vs 30d avg |
|---|---|---|---|---|---|---|---|---|---|
| IBRX $8 call | Aug 28, 2026 | 3d | $0.29 | — | — | — | 2,519 | 2,549 | — |
| IBRX $10 call | Oct 16, 2026 | 52d | $0.40 | — | — | — | 3,453 | 1,838 | — |
| IBRX $8 call | Sep 4, 2026 | 10d | $0.45 | — | — | — | 660 | 1,293 | — |
| IBRX $8.5 call | Aug 28, 2026 | 3d | $0.11 | — | — | — | 1,329 | 1,150 | — |
| IBRX $10 put | Jan 15, 2027 | 143d | $3.20 | — | — | — | 5,176 | 1,007 | — |
| IBRX $9 call | Sep 18, 2026 | 24d | $0.25 | — | — | — | 1,125 | 903 | — |
| IBRX $8.5 call | Sep 4, 2026 | 10d | $0.29 | — | — | — | 250 | 622 | — |
| IBRX $10 call | Jan 15, 2027 | 143d | $1.45 | — | — | — | 69,628 | 498 | — |
| IBRX $14 call | Jan 15, 2027 | 143d | $0.71 | — | — | — | 635 | 402 | — |
| IBRX $13 call | Oct 16, 2026 | 52d | $0.11 | — | — | — | 3,279 | 400 | — |
| IBRX $7 call | Oct 16, 2026 | 52d | $1.70 | — | — | — | 3,279 | 301 | — |
| IBRX $9 call | Oct 16, 2026 | 52d | $0.63 | — | — | — | 1,483 | 246 | — |
| IBRX $7 put | Nov 19, 2027 | 451d | $2.15 | — | — | — | 76 | 217 | — |
| IBRX $8 call | Sep 18, 2026 | 24d | $0.62 | 0.0% | 0 | 1.00 | 1,736 | 215 | 7.6× avg |
| IBRX $2.5 call | Jan 15, 2027 | 143d | $5.50 | — | — | — | 6,091 | 211 | — |
| IBRX $12 call | Oct 16, 2026 | 52d | $0.15 | — | — | — | 827 | 205 | — |
| IBRX $7.5 call | Jan 21, 2028 | 514d | $3.41 | — | — | — | 26,226 | 203 | — |
| IBRX $8 put | Oct 16, 2026 | 52d | $0.90 | — | — | — | 1,245 | 200 | — |
| IBRX $12 call | Jan 15, 2027 | 143d | $1.00 | — | — | — | 6,441 | 196 | — |
| IBRX $9 call | Aug 28, 2026 | 3d | $0.03 | — | — | — | 332 | 195 | — |
| IBRX $7 call | Aug 28, 2026 | 3d | $1.20 | — | — | — | 362 | 193 | — |
| IBRX $11 call | Jan 15, 2027 | 143d | $1.15 | — | — | — | 548 | 171 | — |
| IBRX $15 call | Jan 21, 2028 | 514d | $1.80 | — | — | — | 7,161 | 143 | — |
| IBRX $9 call | Sep 4, 2026 | 10d | $0.14 | — | — | — | 397 | 142 | — |
| IBRX $7.5 put | Jan 15, 2027 | 143d | $1.60 | 0.0% | 0 | 1.00 | 18,516 | 140 | 14.4× avg |
Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.
The most active IBRX contract today is the $8 call expiring in 3 days, with 2,549 contracts traded. Calls dominate the most-active list (21 of the top 25), showing where trading interest concentrates.
Explore the payoff profile of option on IBRX for free
Build multi-leg IBRX strategies, visualize payoffs, and scan the full US options universe with OptiView.
IBRX Options FAQ
Which IBRX option contract is most active today?
The most traded IBRX contract is the $8 call expiring Aug 28, 2026, with 2,549 contracts traded as of Aug 25, 2026.
How does OptiView rank the most active IBRX options?
The table lists the 25 IBRX contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.